Account
Inquiry
QSC tirzepatide is a high-purity peptide compound developed for research applications. This dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist has shown promising results in clinical studies for type 2 diabetes and weight management.
Our pharmaceutical grade QSC tirzepatide is supplied as white powder with 99.9% purity, packaged in convenient 10mg vials (10 vials per box). The molecular structure features PEG modification to enhance water solubility while maintaining biological activity.
In clinical research, QSC tirzepatide has demonstrated superior efficacy compared to selective GLP-1 receptor agonists, with average weight loss reaching 20.9% at the 15mg dose in the SURMOUNT-1 trial. The compound mimics natural GIP action while providing the additional benefits of GLP-1 receptor activation.
Research applications include studies on glucose metabolism, insulin secretion mechanisms, and potential therapeutic approaches for metabolic disorders. The dual agonist properties make QSC tirzepatide particularly valuable for comparative studies with single-receptor agonists.
Proper storage is essential for maintaining peptide integrity. We recommend storing QSC tirzepatide in a cool, dry environment protected from light and moisture. Avoid repeated freeze-thaw cycles and prolonged exposure to solution.
